Renovis Report issue

For profit Phase 2
Founded: South San Francisco CA United States (2000)
Status: Acquired by Kyocera (2019)

Organization Overview

First Clinical Trial
2003
NCT00099528
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2003

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Chief Medical Officer, Renovis, Inc.